1. Market Research
  2. > Biotechnology
  3. > Medical Biotechnology Market Trends
Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

Bioreactors Market by Scale Range, Material, Usage, Suppliers, End-User, Region - Global Forecast to 2021

  • September 2016
  • 115 pages
  • ID: 4194696
  • Format: PDF
  • By MarketsandMarkets

Summary

Table of Contents

Search Inside

The global bioreactors market is expected to reach to USD 1,417 million by 2021 from USD 955 million in 2015, at a CAGR of 6.8% between 2015 and 2021.The increase in adoption of single-use technologies, use of hybrid technologies: Single-use and Stainless Steel, and growing biologics market are propelling the growth of the bioreactors market. Moreover, growing popularity of SUBs among biopharmaceutical companies is also one of the major driver of the global bioreactor market.

However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market.

“Increase in adoption of single-use technologies”
A number of facilities with small-scale systems are being built in favor of single-use bioreactors; this trend is expected to grow during the next five years. Such manufacturing facilities are built using titer and yield data of different molecule class. For instance, in recent times, the average titers at the commercial scale were less than 0.5 grams per liter (g/L). Today, due to technological trends such as improved expression systems and the use of process analytical technologies (PAT), this has this to 2.5 g/L. In future, it is expected that products in this market will have titer approaching 7 g/L. Hence, as the titer increases, companies will have the option of moving to a smaller bioreactor, such as a single-use one.

Nucleo Single-use Bioreactor from Danaher Corporation (U.S.) and Eppendorf AG (Germany), Mobius 3L Bioreactor (Merck KGaA) is some commonly used single-use bioreactors.

“Growing biologics market”
The growth of biologics is driven by monoclonal antibodies and human insulin, which are among the leading contributors to the market. With this growth, the number of bioreactors needed for the R&D and manufacturing of biologics is also expected to grow in the coming years. It is estimated that the R&D investment needed for developing a new medicine is ~USD 1.2 billion. Hence, the growth of biologics is leading to the increase in usage of bioreactors for different upstream bioprocess.

This report provides a detailed competitive landscaping of companies operating in this market. News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies would be detailed.



Reasons to buy this report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends), ranking of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape; emerging and high-growth segments of the bioreactor market; high-growth regions




The report provides insights on the following pointers:

- Market Penetration: Comprehensive information on bioreactors offered by the top players in the global bioreactor market

- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the bioreactors market

- Market Development: Comprehensive information about lucrative emerging markets – the report analyzes the markets for bioreactors across regions

- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global bioreactors market

- Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of the leading players in the global bioreactors market

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Bio Industry Markets in China

Bio Industry Markets in China

  • $ 4000
  • October 2019

China’s demand for Bio Industry has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which ...

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019

  • $ 4000
  • December 2019

Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019SummaryMedical Devices sector report, “Immunochemistry Analyzers - Medical Devices Pipeline Assessment, 2019" provides an overview ...

Anthrax - Pipeline Review, H2 2019

Anthrax - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Anthrax - Pipeline Review, H2 2019SummaryThis latest Pharmaceutical and Healthcare disease pipeline guide Anthrax - Pipeline Review, H2 2019, provides an overview of the Anthrax (Infectious Disease) pipeline ...


ref:plp2016

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on